Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes

Background Variants of the human genes coding for renin, angiotensin-converting enzyme (ACE), angiotensinogen (AGT) and the angiotensin II type-I receptor (AT1R) are inconsistently associated with cardiovascular-renal disease, possibly because of genetic differences in the background populations. Methods This systematic review of the literature investigated genetic variation in the renin system according to race, sex and age. Across studies with relevant information, multivariate analyses also accounted for the methods of genotyping and the enrollment of subjects as controls, cases or groups studied cross-sectionally. Results The 185 reviewed reports included 64978 subjects. In five studies (n = 989) on the renin gene, the Hind III and Taq I polymorphisms varied with the groups' average age, whereas the Bg I, Bg II and Hind III but not Taq I sites differed according to race. Among 135 studies (n = 44697) on the deletion/insertion (D/I) polymorphism of the ACE gene, the frequency of the D allele was 54.0%. Its prevalence was not related to sex and black race, was 49.9% lower in Asians, 10.0% lower in studies relying on I-specific primers, 4.9% higher for each 25-year increment in the average age of the groups studied, and 16.7% higher in cases than controls. Among 12 studies (n = 4952) on the T174rM variant of the AGT gene, the M174 frequency was 11.0%, did not vary according to sex and enrollment group, was 56.7% lower in blacks and 39.5% lower for each 25-year increase in the groups' mean age. Across 44 studies (n = 16713) on the M235rT substitution in the AGT gene, the T235 prevalence was 51.6%. Its frequency was not related to sex and the method of genotyping, tended to be 7.5% lower for each 25-year increase in average age, was from 4.6 to 6.6 times higher in nonwhites than whites and 13.2% higher in cases than controls. Among 13 studies (n = 4332) on the A1166rC variant of the AT1R gene, the C1166 allelic frequency was 25.7%. Its prevalence was independent of the enrollment group, 77.4% lower in Asians, and nearly doubled for each 25-year increment in age. Conclusion With adjustments applied for the subjects' enrollment group and the methods of genotyping, genetic polymorphism in the renin system varies according to race and age, but not sex. One possible application of the present results is to provide allelic and genotypic frequencies, which could be used to assess power, to perform sample size calculations, or to predict selection bias in future studies.

[1]  J. Staessen,et al.  The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular‐renal risk , 1997, Journal of hypertension.

[2]  G. Kajiyama,et al.  Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. , 1997, American journal of hypertension.

[3]  W. Sheu,et al.  Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension , 1997, Journal of hypertension.

[4]  Y. Ko,et al.  Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese , 1997, Human Genetics.

[5]  P. Amouyel,et al.  D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. , 1997, Circulation.

[6]  U. Ikeda,et al.  Angiotensin converting enzyme gene polymorphism in essential hypertension based on ambulatory blood pressure monitoring. , 1997, American journal of hypertension.

[7]  A. Gharavi,et al.  Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension. , 1997, American journal of hypertension.

[8]  P. Amouyel,et al.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. , 1997, Heart.

[9]  T. Sørensen,et al.  ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. , 1997, Circulation.

[10]  C. Rotimi,et al.  Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.

[11]  H. Kawasaki,et al.  Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. , 1997, Life sciences.

[12]  A. Distler,et al.  Genetic variants of the renin–angiotensin system and ambulatory blood pressure in essential hypertension , 1997, Journal of hypertension.

[13]  G Chatellier,et al.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.

[14]  I. Unsal,et al.  Angiotensin converting enzyme gene polymorphism and the risk and extent of ischemic heart disease among Turkish patients. , 1997, Coronary artery disease.

[15]  P. Amouyel,et al.  The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. , 1997, Journal of the American College of Cardiology.

[16]  F. Perticone,et al.  Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. , 1997, Journal of the American College of Cardiology.

[17]  R. Ward,et al.  ACE, angiotensinogen and obesity: a potential pathway leading to hypertension , 1997, Journal of Human Hypertension.

[18]  I. Borecki,et al.  Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. , 1997, Annals of epidemiology.

[19]  I. Borecki,et al.  Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. , 1997, Annals of epidemiology.

[20]  K. Thai,et al.  Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. , 1997, Kidney international.

[21]  R. Kunz,et al.  Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension , 1997, Diabetologia.

[22]  P. Ducimetiere,et al.  Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study , 1996, Human Genetics.

[23]  R. Zulli,et al.  Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. , 1996, Hypertension.

[24]  S. Ito,et al.  Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies , 1996, Journal of hypertension.

[25]  D. Levy,et al.  Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. , 1996, The New England journal of medicine.

[26]  A. Rantala,et al.  Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis , 1996, Journal of hypertension.

[27]  Y. Friedlander,et al.  M235→ T polymorphism of the angiotensinogen gene predicts hypertension in the elderly , 1996, Journal of hypertension.

[28]  A. Maxwell,et al.  A Molecular Variant of Angiotensinogen Is Associated With Diabetic Nephropathy in IDDM , 1996, Diabetes.

[29]  E. Schwartz,et al.  Absence of association between the angiotensin-converting enzyme gene polymorphism and borderline hypertension in men of St Petersburg, Russia. , 1996, Journal of human hypertension.

[30]  Y. Yazaki,et al.  Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. , 1996, Coronary artery disease.

[31]  H. Schunkert,et al.  Association of angiotensin converting enzyme activity and arterial blood pressure in a population-based sample. , 1996, Journal of hypertension.

[32]  M. Ishida,et al.  Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. , 1996, Hypertension.

[33]  G. MacGregor,et al.  Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. , 1996, Kidney international.

[34]  B. Julian,et al.  Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. , 1996, Kidney international.

[35]  J. Ménard,et al.  Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.

[36]  S. Douma,et al.  Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. , 1995, American journal of hypertension.

[37]  M. Stowasser,et al.  Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. , 1996, Journal of human hypertension.

[38]  P. Talmud,et al.  The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? , 1995, Circulation.

[39]  M. Offidani,et al.  Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low‐risk population , 1995, Journal of hypertension.

[40]  J. Critchley,et al.  Angiotensin converting enzyme insertion-deletion polymorphism in Chinese. , 1995, Journal of hypertension.

[41]  J. Staessen,et al.  Heritability of conventional and ambulatory blood pressures. A study in twins. , 1995, Hypertension.

[42]  E. Arbustini,et al.  Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. , 1995, British heart journal.

[43]  N. Hübner,et al.  Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical complex phenotypes in human and rat hypertension. , 1995, Circulation.

[44]  C. Ponticelli,et al.  No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  I. Ichikawa,et al.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. , 1995, The Journal of clinical investigation.

[46]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[47]  M. Caulfield,et al.  Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. , 1995, The Journal of clinical investigation.

[48]  F. Cambien,et al.  Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. , 1995, Hypertension.

[49]  K. Kario,et al.  Effect of the angiotensinogen gene Met235$Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations , 1995, Journal of hypertension.

[50]  J. Connell,et al.  Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy , 1995, The Lancet.

[51]  K. Lindpaintner,et al.  Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. , 1995, Circulation.

[52]  J. Higaki,et al.  Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. , 1995, Hypertension.

[53]  H. Parving,et al.  Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients , 1995, Diabetes.

[54]  N. Iwai,et al.  Angiotensinogen gene and blood pressure in the Japanese population. , 1995, Hypertension.

[55]  R Kreutz,et al.  A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. , 1995, The New England journal of medicine.

[56]  T. Iwamoto,et al.  Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. , 1995, American journal of hypertension.

[57]  R. Hegele,et al.  A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. , 1994, Circulation.

[58]  K. Nakai,et al.  Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. , 1994, Circulation.

[59]  C. Rotimi,et al.  Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. , 1994, Hypertension.

[60]  M. Perola,et al.  Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. , 1994, The American journal of physiology.

[61]  P. Munroe,et al.  ACE insertion/deletion (I/D) polymorphism in Vincentian African Caribbeans with essential hypertension. , 1994, Journal of human hypertension.

[62]  G. Sagnella,et al.  Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin , 1994, Journal of hypertension.

[63]  N. Markandu,et al.  Angiotensinogen Met235-->Thr polymorphism in a London normotensive and hypertensive black and white population. , 1994, Journal of human hypertension.

[64]  L. Tiret,et al.  Plasma Level and Gene Polymorphism of Angiotensin‐Converting Enzyme in Relation to Myocardial Infarction , 1994, Circulation.

[65]  P. Kubilis,et al.  Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. , 1994, American journal of hypertension.

[66]  T. Ogihara,et al.  Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. , 1994, Journal of human hypertension.

[67]  H. Schunkert,et al.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. , 1994, The New England journal of medicine.

[68]  A. Krolewski,et al.  Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene , 1994, Diabetes.

[69]  F. Cambien,et al.  Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  F. Cambien,et al.  Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications , 1994, Diabetes.

[71]  J. Lalouel,et al.  Angiotensinogen as a risk factor for essential hypertension in Japan. , 1994, The Journal of clinical investigation.

[72]  Y. Michishita,et al.  Angiotensin-converting enzyme gene polymorphism in haemodialysis patients , 1994, The Lancet.

[73]  T. Morise,et al.  Angiotensin-converting enzyme polymorphism and essential hypertension , 1994, The Lancet.

[74]  Yasuyuki Nakamura,et al.  Molecular Variants of the Angiotensinogen Gene and Hypertension in a Japanese Population , 1994 .

[75]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[76]  J. Erikssen,et al.  Insertion /deletion (I/D) polymorphism at the locus for angiotensin I‐converting enzyme and parental history of myocardial infarction , 1993, Clinical genetics.

[77]  T. Ogihara,et al.  A potent genetic risk factor for restenosis , 1993, Nature Genetics.

[78]  T. Beaty,et al.  Fundamentals of Genetic Epidemiology , 1993 .

[79]  D. Grobbee,et al.  Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study , 1993, Journal of hypertension.

[80]  O. Costerousse,et al.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. , 1993, The Biochemical journal.

[81]  A. Wilkie Medical genetics: advances in brief , 1993 .

[82]  A. Riches,et al.  The mechanism of action of the tetrapeptide Acetyl‐N‐Ser‐Asp‐Lys‐Pro (AcSDKP) in the control of haematopoietic stem cell proliferation , 1992, Cell proliferation.

[83]  U. Ravnskov,et al.  Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. , 1992, BMJ.

[84]  P. C. White,et al.  Genetic analysis of the human type-1 angiotensin II receptor. , 1992, Molecular endocrinology.

[85]  H. Dustan Growth factors and racial differences in severity of hypertension and renal diseases , 1992, The Lancet.

[86]  B. Morris,et al.  Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. , 1992, Biochemical and biophysical research communications.

[87]  F. Soubrier,et al.  PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). , 1992, Nucleic acids research.

[88]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[89]  C. Grim,et al.  Biohistory of Slavery and Blood Pressure Differences in Blacks Today A Hypothesis , 1991, Hypertension.

[90]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[91]  N. Poulter,et al.  The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. , 1990, BMJ.

[92]  B. Morris,et al.  Frequency in hypertensives of alleles for a RFLP associated with the renin gene. , 1988, Biochemical and biophysical research communications.

[93]  S. Srinivasan,et al.  Black-white contrasts as determinants of cardiovascular risk in childhood: precursors of coronary artery and primary hypertensive diseases. , 1984, American heart journal.